Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury.
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Sepsis-induced lung injury is a persisting clinical problem with no direct therapy. Recent work suggests that intravenously infused ascorbic acid improves the circulatory dysfunction of sepsis. We used a model of endotoxin-induced acute lung injury to determine whether parenteral ascorbic acid modulates the dysregulated proinflammatory, procoagulant state that leads to lung injury. DESIGN: C57BL/6 mice were exposed to lethal lipopolysaccharide doses (10 μg/g of body weight) to induce acute lung injury. SETTING: Laboratory investigation. SUBJECTS: Wild-type C57BL/6 mice. INTERVENTIONS: Ascorbic acid or its oxidized form (dehydroascorbic acid) was administered intraperitoneally at 200 mg/kg 30 mins after the lethal lipopolysaccharide dose. MEASUREMENTS AND MAIN RESULTS: We quantified survival, lung capillary leak, proinflammatory chemokine expression, and lung microvascular thrombosis. Lipopolysaccharide induced 100% lethality in mice within 28 hrs of exposure and in lung we observed intense neutrophil sequestration, loss of capillary barrier function, exuberant pulmonary inflammation, and extensive microthrombus formation. A time-delayed infusion protocol of both ascorbic acid and dehydroascorbic acid significantly prolonged survival. Both ascorbic acid and dehydroascorbic acid preserved lung architecture and barrier function while attenuating proinflammatory chemokine expression and microvascular thrombosis. Ascorbic acid and dehydroascorbic acid attenuated nuclear factor kappa B activation and normalized coagulation parameters. CONCLUSIONS: Ascorbic acid administered in an interventional manner following lipopolysaccharide infusion attenuates proinflammatory, procoagulant states that induce lung vascular injury in an animal model of sepsis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Vitamin C increased alveolar fluid clearance by preventing activated neutrophil accumulation in alveolar spaces, limiting alveolar epithelial water-channel damage, and promoting their increased expression.14”
In the citing paper
“Preclinical research in early sepsis revealed that vitamin C prevented sepsis-induced cytokine surges that activate and sequester neutrophils in lung, thus damaging alveolar capillaries.13,14”
Citations
Cites
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742 · cited 1×
“Furthermore, it is generally agreed that it is not the bacterial infection itself, but rather the inflammatory response to infection that is the predominant determinant of outcomes in sepsis (25, 26).”
BackgroundHMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line
Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., & Lawley, T. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613748 · Cited by 1,265 · cited 1×
“The human microvascular endothelial cell line HMEC-1 was obtained from the Centers for Disease Control and Prevention (Atlanta, GA) (15) and cultured as described in the online supplement (Supplemental Digital Content 1, http:// links.”
MethodSepsis: A New Hypothesis for Pathogenesis of the Disease Process
Bone, R. C., Grodzin, C. J., & Balk, R. A. (1997) · Chest · doi:10.1378/chest.112.1.235 · Cited by 1,021
Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J., & Levine, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804226105 · Cited by 854 · cited 1×
“Although AscA can also be a pro-oxidant, generating hydrogen peroxide-dependent cytotoxicity toward cancer cells without affecting normal cells, the doses of AscA required for its pro-oxidant effects are several-fold higher than those used in the current study (39).”
BackgroundNishikimi, M., Fukuyama, R., Minoshima, S., Shimizu, N., & Yagi, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36884-9 · Cited by 503 · cited 1×
“Ascorbic acid (AscA) is an essential vitamin for humans who lack L-gulono-lactone oxidase, the final enzyme in the biosynthetic pathway for AscA (8).”
BackgroundMatthay, M. A., Zimmerman, G. A., Esmon, C., Bhattacharya, J., Coller, B., Doerschuk, C. M., Floros, J., Gimbrone, M. A., Hoffman, E., Hubmayr, R. D., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-966ws · Cited by 496
A new recommended dietary allowance of vitamin C for healthy young women
Levine, M., Wang, Y., Padayatty, S. J., & Morrow, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171318198 · Cited by 496 · cited 1×
“Although AscA circulates in human plasma at approximately 30–50 M, it accumulates in millimolar concentrations in host defense cells (11).”
BackgroundMammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid
Vera, J. C., Rivas, C. I., Fischbarg, J., & Golde, D. W. (1993) · Nature · doi:10.1038/364079a0 · Cited by 496
Mechanisms of sepsis-induced organ dysfunction
Abraham, E., & Singer, M. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282072.56245.91 · Cited by 442
Research works printed but not linked: 2
- Knowles, 2003, Cancer Res, 63, 1764
- Lehr, 2006, Eur J Med Res, 11, 516
Cited by
Acute respiratory distress syndrome
Meyer, N. J., Gattinoni, L., & Calfee, C. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00439-6 · Cited by 1,144
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Fowler, A. A., Truwit, J. D., Hite, R. D., Morris, P. E., DeWilde, C., Priday, A., Fisher, B., Thacker, L. R., Natarajan, R., Brophy, D. F., et al. (2019) · JAMA · doi:10.1001/jama.2019.11825 · Cited by 836
Self-citationPhase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
Nursing, M. R. I. C. U., Fowler, A. A., Syed, A. A., Knowlson, S., Sculthorpe, R., Farthing, D., DeWilde, C., Farthing, C. A., Larus, T. L., Martin, E., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-32 · Cited by 573
“Recently, we showed that parenterally infusing ascorbic acid at a concentration of 200 mg/kg attenuated vascular lung injury in septic mice by multiple mechanisms, including attenuation of the proinflammatory mediators, enhanced alveolar epithelial barrier function, increased alveolar fluid clearance, and prevention o…”
BackgroundSelf-citationKellner, M., Noonepalle, S., Lu, Q., Srivastava, A., Zemskov, E., & Black, S. M. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-63245-2_8 · Cited by 402
Impact of Childhood Malnutrition on Host Defense and Infection
Ibrahim, M. K., Zambruni, M., Melby, C. L., & Melby, P. C. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00119-16 · Cited by 344
The effects of sepsis on endothelium and clinical implications
Dolmatova, E. V., Wang, K., Mandavilli, R., & Griendling, K. K. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa070 · Cited by 317
“In animal models of vascular injury due to endotoxaemia, reperfusion injury, ARDS, and burns, vitamin C administration preserved lung barrier function, prevented oedema formation in burns and decreased ROS production.(154,155) These promising experimental data combined with the fact that the levels of vitamin C in cri…”
BackgroundOudemans-van Straaten, H. M., Man, A. M. S.-D., & de Waard, M. C. (2014) · Critical Care · doi:10.1186/s13054-014-0460-x · Cited by 299
“after LPS [54] Attenuates sepsis-induced acute lung injury and improves 72-h survival Preserves lung architecture and barrier”
BackgroundVan de Bittner, G. C., Bertozzi, C. R., & Chang, C. J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309078t · Cited by 292
Current status of potential therapeutic candidates for the COVID-19 crisis
Zhang, J., Xie, B., & Hashimoto, K. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.046 · Cited by 283
“In animal models of sepsis, vitamin C was shown to protect lung barrier function and reduce lung vascular injury through diminishing inflammatory responses and coagulant changes (Fisher et al., 2012; Fisher et al., 2011).”
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
Zhang, J., Rao, X., Li, Y., Zhu, Y., Liu, F., Guo, G., Luo, G., Meng, Z., De Backer, D., Xiang, H., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-020-00792-3 · Cited by 253
Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid.
Fisher, B. J., Kraskauskas, D., Martin, E. J., Farkas, D., Wegelin, J. A., Brophy, D., Ward, K. R., Voelkel, N. F., Fowler, A. A., & Natarajan, R. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2011 · Cited by 231
Self-citationSchönrich, G., Raftery, M. J., & Samstag, Y. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100741 · Cited by 220
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
Infusino, F., Marazzato, M., Mancone, M., Fedele, F., Mastroianni, C. M., Severino, P., Ceccarelli, G., Santinelli, L., Cavarretta, E., Marullo, A. G. M., et al. (2020) · Nutrients · doi:10.3390/nu12061718 · Cited by 203
Vitamin C: a novel regulator of neutrophil extracellular trap formation.
Mohammed, B., Fisher, B., Kraskauskas, D., Farkas, D., Brophy, D., Fowler, A., & Natarajan, R. (2013) · Nutrients · doi:10.3390/nu5083131 · Cited by 187
“We have previously shown that VitC blocks NFκB activation in septic mouse lungs [12].”
BackgroundMethodInfluentialSelf-citationThe Emerging Role of Vitamin C as a Treatment for Sepsis
Kashiouris, M. G., L’Heureux, M., Cable, C. A., Fisher, B. J., Leichtle, S. W., & Fowler, A. A. (2020) · Nutrients · doi:10.3390/nu12020292 · Cited by 177
“Vitamin C also regulates nuclear cellular responses to stress and hypoxia by regulating HIF-1α [40,49,52,62,123], produces NF-κB epigenetic modifications [124] through its ability to de-methylate histones [75,82,87–89,125,126], regulates pro-inflammatory and coagulation gene expression [28,41,42,44,123,125–127], and o…”
BackgroundSelf-citationCerullo, G., Negro, M., Parimbelli, M., Pecoraro, M., Perna, S., Liguori, G., Rondanelli, M., Cena, H., & D’Antona, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574029 · Cited by 158
Vitamin C promotes wound healing through novel pleiotropic mechanisms
Mohammed, B. M., Fisher, B. J., Kraskauskas, D., Ward, S., Wayne, J. S., Brophy, D. F., Fowler, A. A., Yager, D. R., & Natarajan, R. (2016) · International Wound Journal · doi:10.1111/iwj.12484 · Cited by 169
Self-citationVitamin C for the treatment of sepsis: The scientific rationale
Marik, P. E. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.007 · Cited by 164
JamaliMoghadamSiahkali, S., Zarezade, B., Koolaji, S., SeyedAlinaghi, S., Zendehdel, A., Tabarestani, M., Sekhavati Moghadam, E., Abbasian, L., Dehghan Manshadi, S. A., Salehi, M., et al. (2021) · European Journal of Medical Research · doi:10.1186/s40001-021-00490-1 · Cited by 156
“The impact of vitamin C administration on alleviating lung injury has also been investigated and supported in other studies [14].”
ResultImmunotherapy in sepsis - brake or accelerate?
Steinhagen, F., Schmidt, S. V., Schewe, J., Peukert, K., Klinman, D. M., & Bode, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107476 · Cited by 164
Kim, W.-Y., Jo, E.-J., Eom, J. S., Mok, J., Kim, M.-H., Kim, K. U., Park, H.-K., Lee, M. K., & Lee, K. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.07.004 · Cited by 130
“First, experimental studies on sepsis-induced lung injury show that vitamin C treatment diminishes the proinflammatory and procoagulant changes that induce lung injury [35].”
BackgroundEvaluation of Vitamin C for Adjuvant Sepsis Therapy
Wilson, J. X. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5401 · Cited by 99
“Ascorbate (200 mg/kg) or DHAA (200 mg/kg) injection mitigates this LPS-induced hypocoagulability in systemic blood (17).”
BackgroundInfluentialFowler III, A. A., Kim, C., Lepler, L., Malhotra, R., Debesa, O., Natarajan, R., Fisher, B. J., Syed, A., DeWilde, C., Priday, A., et al. (2017) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v6.i1.85 · Cited by 99
“Our work thus far shows vitamin C to exert potent "pleotropic effects" when used as described in this report.”
BackgroundSelf-citationManohar, T. S., Balan, V., & Sivaramakrishnan, V. (2020) · Phytotherapy Research · doi:10.1002/ptr.6794 · Cited by 114
“Similar results were obtained in independent studies using sepsis and acute lung injury models treated with or without vitamin-C (200 mg/kg) (Fisher et al., 2011, 2012).”
ResultPossible application of high-dose vitamin C in the prevention and therapy of coronavirus infection
Hoang, B. X., Shaw, G., Fang, W., & Han, B. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.09.025 · Cited by 90
Attenuation of Sepsis‐Induced Organ Injury in Mice by Vitamin C
Fisher, B. J., Kraskauskas, D., Martin, E. J., Farkas, D., Puri, P., Massey, H. D., Idowu, M. O., Brophy, D. F., Voelkel, N. F., Fowler, A. A., et al. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113497760 · Cited by 88
Self-citationGao, D., Xu, M., Wang, G., Lv, J., Ma, X., Guo, Y., Zhang, D., Yang, H., Jiang, W., Deng, F., et al. (2021) · Aging · doi:10.18632/aging.202557 · Cited by 92
“A large number of studies have confirmed that high-dose vitamin C can benefit patients with lung injury caused by various inflammatory diseases, especially ARDS and sepsis [27, 30, 33, 34].”
BackgroundWang, Y., Lin, H., Lin, B., & Lin, J. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0532-9 · Cited by 85
Vitamin C: The next Step in Sepsis Management?
Teng, J., Pourmand, A., & Mazer-Amirshahi, M. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.09.031 · Cited by 82
Kuhn, S.-O., Meissner, K., Mayes, L. M., & Bartels, K. (2018) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000549 · Cited by 82
Vitamin C supplementation in the critically ill: A systematic review and meta-analysis
Zhang, M., & Jativa, D. F. (2018) · SAGE Open Medicine · doi:10.1177/2050312118807615 · Cited by 76
Hager, D. N., Hooper, M. H., Bernard, G. R., Busse, L. W., Ely, E. W., Fowler, A. A., Gaieski, D. F., Hall, A. J., Hinson, J. S., Jackson, J. C., et al. (2019) · Trials · doi:10.1186/s13063-019-3254-2 · Cited by 77
Self-citationKim, S. R., Ha, Y. M., Kim, Y. M., Park, E., Kim, J. W., Park, S. W., Kim, H. J., Chung, H., & Chang, K. C. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.007 · Cited by 73
Reversal of the Pathophysiological Responses to Gram-Negative Sepsis by Megadose Vitamin C
Lankadeva, Y. R., Peiris, R. M., Okazaki, N., Birchall, I. E., Trask-Marino, A. L., Dornom, A., Vale, T. A. M., Evans, R. G., Yanase, F., Bellomo, R., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004770 · Cited by 73
“This is in accord with findings that ascorbic acid attenuated the proinflammatory and procoagulant state that induced vascular lung injury in mice challenged with lipopolysaccharide (39, 40).”
ResultBelsky, J. B., Wira, C. R., Jacob, V., Sather, J. E., & Lee, P. J. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422418000124 · Cited by 69
“Vitamin C is involved in attenuating the proinflammatory and procoagulant state which induces vascular–ischaemic-induced organ injury((65,66)).”
BackgroundVitamin C and Microvascular Dysfunction in Systemic Inflammation
Tyml, K. (2017) · Antioxidants · doi:10.3390/antiox6030049 · Cited by 59
“Importantly, we and others have shown that intravenous injection of ascorbate protects against sepsis-induced capillary plugging and organ injury [17,40,48,50].”
BackgroundResultUnusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C
Khan, H. M. W., Parikh, N. M., Megala, S. M., & Predeteanu, G. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.925521 · Cited by 70
Mahmoodpoor, A., Shadvar, K., Sanaie, S., Hadipoor, M. R., Pourmoghaddam, M. A., & Saghaleini, S. H. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06288-0 · Cited by 61
Zhou, G., Kamenos, G., Pendem, S., Wilson, J. X., & Wu, F. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2011 · Cited by 57
“Other studies have shown that intravenous administration of ascorbate decreases edema formation in LPS-injected or burninjured animal models of critical illness (11, 12, 15, 42, 48).”
BackgroundBharara, A., GROSSMAN, C. E., Grinnan, D., Syed, A. A., Fisher, B., DeWilde, C., Natarajan, R., & Fowler, A. A. (2016) · Case Reports in Critical Care · doi:10.1155/2016/8560871 · Cited by 58
Self-citationVitamin C in Health and Disease: A Companion Animal Focus
Gordon, D. S., Rudinsky, A. J., Guillaumin, J., Parker, V. J., & Creighton, K. J. (2020) · Topics in companion animal medicine · doi:10.1016/j.tcam.2020.100432 · Cited by 65
Sulaiman, K. A. A., Aljuhani, O. A., Saleh, K. B., Badreldin, H. A., Harthi, A. A., Alenazi, M., Alharbi, A. A., Algarni, R., Harbi, S. A. A., Alhammad, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96703-y · Cited by 56
Zhang, N., Zhao, W., Hu, Z., Ge, S., Huo, Y., Liu, L., & Gao, B.-L. (2021) · Scientific Reports · doi:10.1038/s41598-021-93861-x · Cited by 61
Hemilä, H., & de Man, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.559811 · Cited by 48
“In addition, in septic mice with acute respiratory distress syndrome (ARDS), vitamin C administration downregulated proinflammatory genes, enhanced epithelial barrier function, and improved alveolar fluid clearance (9, 10).”
BackgroundQiao, X., Kashiouris, M. G., L'Heureux, M., Fisher, B. J., Leichtle, S. W., Truwit, J. D., Nanchal, R. S., Hite, R. D., Morris, P. E., Martin, G. S., et al. (2022) · Nutrients · doi:10.3390/nu14204415 · Cited by 48
Self-citationVitamins, supplements and COVID-19: a review of currently available evidence
Speakman, L., Michienzi, S. M., & Badowski, M. E. (2021) · Drugs in Context · doi:10.7573/dic.2021-6-2 · Cited by 51
Vitamin C improves microvascular reactivity and peripheral tissue perfusion in septic shock patients
Lavillegrand, J., Raia, L., Urbina, T., Hariri, G., Gabarre, P., Bonny, V., Bigé, N., Baudel, J.-L., Bruneel, A., Dupré, T., et al. (2022) · Critical Care · doi:10.1186/s13054-022-03891-8 · Cited by 44
“Several potential beneficial effects of vitamin C have been reported in both animal [9, 10] and human studies [11], including (1) antioxidant properties (scavenging of reactive oxygen species) [12, 13], (2) downregulation of pro-inflammatory gene expression (cytokines, chemokines), (3) restoration of immune cell activ…”
BackgroundRETRACTED ARTICLE: Early use of high-dose vitamin C is beneficial in treatment of sepsis
Lv, S., Guo-hu, Z., Xia, J., Yu, H., & Zhao, F. (2020) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02394-1 · Cited by 46
RetractedCovid 19: Diet Composition and Health
Skrajnowska, D., Brumer, M., Kankowska, S., Matysek, M., Miazio, N., & Bobrowska‐Korczak, B. (2021) · Nutrients · doi:10.3390/nu13092980 · Cited by 39
Zhao, B., Fei, J., Chen, Y., Ying, Y., Ma, L., Song, X., Huang, J., Chen, E., & Mao, E. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-442 · Cited by 39
“conditions, such as sepsis [12], cardiac arrest [13] and”
BackgroundSae‐khow, K., Tachaboon, S., Wright, H. L., Edwards, S. W., Srisawat, N., Leelahavanichkul, A., & Chiewchengchol, D. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s252433 · Cited by 38
Xiao, L., Huang, Y., Zu, D., Liu, H., He, H., Bao, Q., He, Y., Liang, C., Luo, G., Teng, Y., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117284 · Cited by 39
Ahn, J. H., Oh, D. K., Huh, J. W., Lim, C., Koh, Y., & Hong, S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.03.03 · Cited by 36
“Chronic kidney disease 10 [13] 4 [11] 6 [15] 0.”
Lim, E. Y., Lee, S., Shin, H. S., & Kim, G.-D. (2023) · Antioxidants · doi:10.3390/antiox12112016 · Cited by 46
“Fisher et al. [217] showed that intraperitoneally delivered vitamin C ameliorated LPS-induced pulmonary inflammation and procoagulant activity in a murine septic lung injury model.”
BackgroundBae, S., Cho, C., Kim, H., Kim, Y., Kim, H., Hwang, Y., Yoon, J., Kang, J. S., & Lee, W. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4756 · Cited by 52
“In an animal model of sepsis, vitamin C administration suppresses inflammation in the lung and decreases oxidative damages and lipid peroxidation in the liver (2, 10).”
BackgroundHigh-dose vitamin C infusion for the treatment of critically ill COVID-19Preprint
Zhang, J., Rao, X., Li, Y., Zhu, Y., Liu, F., Guo, G., Luo, G., Meng, Z., Backer, D. D., Xiang, H., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-52778/v1 · Cited by 37
“In sepsis modeling of mice, parenterally infused VC demonstrated a protective effect on the lung [38, 39].”
BackgroundVitamin C for the critically ill: Is the evidence strong enough?
Langlois, P. L., & Lamontagne, F. (2018) · Nutrition · doi:10.1016/j.nut.2018.10.009 · Cited by 35
Dual Role of Hydrogen Peroxide as an Oxidant in Pneumococcal Pneumonia
Mraheil, M. A., Toque, H. A., Pietra, L. L., Hamacher, J., Phanthok, T., Verin, A. D., Gonzales, J., Su, Y., Fulton, D. J., Eaton, D. C., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7964 · Cited by 32
“Especially noteworthy are promising preclinical data with the potent antioxidant ascorbic acid (vitamin C), which in preclinical studies was shown to attenuate systemic inflammation and blunt sepsis-induced coagulopathy and vascular injury (40, 41, 43).”
BackgroundVitamin C in Critically Ill Patients: An Updated Systematic Review and Meta-Analysis
Shrestha, D. B., Budhathoki, P., Sedhai, Y. R., Mandal, S. K., Shikhrakar, S., Karki, S., Baniya, R. K., Kashiouris, M. G., Qiao, X., & Fowler, A. A. (2021) · Nutrients · doi:10.3390/nu13103564 · Cited by 32
Self-citationIs High-Dose Vitamin C Beneficial for Patients With Sepsis?
Brant, E. B., & Angus, D. C. (2019) · JAMA · doi:10.1001/jama.2019.11643 · Cited by 29
Pharmacologic Treatments for Acute Respiratory Distress Syndrome
Qadir, N., & Chang, S. Y. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2021.05.009 · Cited by 32
Hemilä, H., & Chalker, E. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01254-8 · Cited by 32
Vitamin C for sepsis intervention: from redox biochemistry to clinical medicine
Li, Y. R., & Zhu, H. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04240-z · Cited by 30
IV Vitamin C in Critically Ill Patients: A Systematic Review and Meta-Analysis.
Patel, J. J., Ortiz‐Reyes, L., Dhaliwal, R., Clarke, J., Hill, A., Stoppe, C., Lee, Z., & Heyland, D. K. (2022) · PubMed · doi:10.1097/ccm.0000000000005320 · Cited by 29
Şahin, E., Orhan, C., Uckun, F. M., & Şahin, K. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.580504 · Cited by 29
“In addition, a time-delayed infusion protocol of both ascorbic acid and dehydroascorbic acid attenuated pro-inflammatory, procoagulant states that induce lung vascular damage and significantly prolonged survival (110).”
BackgroundImpact of high dose vitamin C on platelet function
Mohammed, B. M., Sanford, K., Fisher, B. J., Martin, E. J., Contaifer, D., Warncke, U. O., Wijesinghe, D. S., Chalfant, C. E., Brophy, D. F., Fowler, A. A., et al. (2017) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v6.i1.37 · Cited by 29
Self-citationReynolds, P. S., Fisher, B. J., McCarter, J., Sweeney, C., Martin, E. J., Middleton, P., Ellenberg, M., Fowler, E., Brophy, D. F., Fowler, A. A., et al. (2018) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001844 · Cited by 25
Self-citationZheng, H. X., Jin, S., Li, T., Ying, W., Ying, B., Chen, D., Ning, J., Zheng, C., Li, Y., Li, C., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.03.039 · Cited by 25
“We speculate that DAA can be converted to ascorbic acid, and thereby exhibits a protective effect on lung injury [64].”
Vitamin C and thiamine are associated with lower mortality in sepsis
Byerly, S. E., Parreco, J. P., Soe-Lin, H., Parks, J. J., Lee, E. E., Shnaydman, I., Mantero, A. M. A., Yeh, D. D., Namias, N., & Rattan, R. (2020) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002613 · Cited by 25
Aschauer, S., Gouya, G., Klickovic, U., Storka, A., Weisshaar, S., Vollbracht, C., Krick, B., Weiss, G., & Wolzt, M. (2014) · Vascular Pharmacology · doi:10.1016/j.vph.2014.01.007 · Cited by 23
Vitamin C: Rationale for Its Use in Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
Fowler, A. A. (2024) · Antioxidants · doi:10.3390/antiox13010095 · Cited by 25
“…studies using the feces-induced peritonitis model of acute lung injury, Fisher and colleagues showed that vitamin C infusion significantly attenuated NF-κ B activation, which occurred following the onset of sepsis-induced acute lung injury [68]. of acute Antioxidants 2024 , 13 , x FOR PEER 16 .”
MethodSelf-citationFujii, T., Udy, A. A., Deane, A. M., Luethi, N., Bailey, M., Eastwood, G. M., Frei, D. R., French, C., Orford, N. R., Shehabi, Y., et al. (2019) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00661-0 · Cited by 23
Investigational pharmacological agents for the treatment of ARDS
Aribindi, K., Lim, M., Lakshminrusimha, S., & Albertson, T. E. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2315128 · Cited by 23
“The primary outcome was defined as a composite score of all cause mortality, ECMO treatment and venous or arterial thrombosis at 30 days, and results demonstrated no clinical difference between atorvastatin and placebo [95/290 (33”
BackgroundImpact of Intravenous Ascorbic Acid Infusion on Novel Biomarkers in Patients with Severe Sepsis
Natarajan, R. (2014) · Journal of Pulmonary & Respiratory Medicine · doi:10.4172/2161-105x.1000214 · Cited by 25
“In our pre-clinical studies, we showed that parenteral infusion of ascorbic acid (200 mg/kg) could attenuate sepsis induced organ injury in wild type mice [2,3] and in vitamin C knockout mice (lacking L-gulono-γ-lactone oxidase, Gulo) [4].”
BackgroundResultSelf-citationJamshidi, M. R., Zeraati, M. R., Forouzanfar, B., Tahrekhani, M., & Motamed, N. (2021) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_593_19 · Cited by 28
“[20] Vitamin C improves endothelial dysfunction by reducing the production of free oxygen radicals.”
BackgroundLin, Y., Alhaskawi, A., Chen, L., & Moqbel, S. A. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1695992 · Cited by 27
Wu, T., Hu, C., Huang, W., Xu, Q., Hu, B., & Li, J. (2021) · Shock · doi:10.1097/shk.0000000000001781 · Cited by 26
“Animal experiments have shown that ascorbic acid may attenuate nuclear factor kappa B activation resulting in proinflammatory mediator expression reduction in sepsis (34).”
BackgroundA Cecal Slurry Mouse Model of Sepsis Leads to Acute Consumption of Vitamin C in the Brain
Consoli, D. C., Jesse, J. J., Klimo, K. R., Tienda, A. A., Putz, N. D., Bastarache, J. A., & Harrison, F. E. (2020) · Nutrients · doi:10.3390/nu12040911 · Cited by 25
“ASC administration during sepsis also attenuates acute lung injury [27] and improves multiple organ dysfunction syndrome in animal models of sepsis [28,29].”
BackgroundMonitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies
Typpo, K., Wong, H. R., Finley, S. D., Daniels, R. C., SEELY, A. J. E., & Lacroix, J. (2017) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000001050 · Cited by 21
Wang, X., Zhou, L., Ye, S., Liu, S., Chen, L., Cheng, Z., Huang, Y., Wang, B., Pan, M., Wang, D., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109923 · Cited by 20
Üstündağ, H., Demir, Ö., Çiçek, B., Huyut, M. T., Yüce, N., & Tavacı, T. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13780 · Cited by 23
“studies have shown that ASA treatment can significantly reduce tissue damage caused by sepsis through improvement of the antioxidant defence system and reduction of oxidative stress.(4,21,27,44) Our study found that the use of combination therapy with MEL and ASA was more effective in reducing oxidative stress and imp…”
BackgroundResultRossetti, M., Martucci, G., Starchl, C., & Amrein, K. (2021) · Medicina · doi:10.3390/medicina57050419 · Cited by 20
“In septic patients, vitamin C is involved in the modulation of the proinflammatory and procoagulant state bel eved to induce vascular-i chemic induced multiple organ injury [48].”
BackgroundCITRIS-ALI: How statistics were used to obfuscate the true findings
Marik, P. E., & Payen, D. M. (2019) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2019.10.004 · Cited by 18
Ascorbic acid attenuates activation and cytokine production in sepsis-like monocytes
Schmidt, T., Kahn, R., & Kahn, F. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ab0521-243r · Cited by 18
“, the vascular and pulmonary systems (17-20).”
Ascorbic Acid in the Acute Care Setting
Kressin, C., Pandya, K. A., Magnuson, B. L., Donaldson, C., & Flannery, A. H. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2102 · Cited by 17
Shaghaghi, H., Kadlecek, S. J., Siddiqui, S. M., Pourfathi, M., Hamedani, H., Clapp, J. T., Profka, H., & Rizi, R. R. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.042 · Cited by 17
“Ascorbate administration has been shown to reduce oxidative damage in endothelial cells [30, 31], improve tissue perfusion [32], inhibit tumor necrosis factor α (TNFα) [33], reduce mitochondrial swelling and damage [27], preserve mitochondrial respiration [34], reduce edema [35], reduce proinflammatory chemokine expre…”
Driny, W. A. E., Esmat, I. M., Shaheen, S. M., & Sabri, N. A. (2022) · Anesthesiology Research and Practice · doi:10.1155/2022/4057215 · Cited by 16
“Patients with sepsis may develop acute lung injury that is characterized by activation of tissue inflammation and reactive oxygen species (ROS) production [4].”
BackgroundInfluential“Vitamin S” (Steroids) and Vitamin C for the Treatment of Severe Sepsis and Septic Shock!*
Marik, P. E. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001684 · Cited by 16
“In experimental and clinical studies, high-dose IV vitamin C has been shown to decrease NF-κβ activation, with a reduction inflammatory markers and organ dysfunction (15, 16).”
BackgroundVitamin C as a treatment for organ failure in sepsis
Wang, Z., Liu, L., & Liu, L. (2023) · European journal of medical research · doi:10.1186/s40001-023-01183-7 · Cited by 17
Moesin Is a Novel Biomarker of Endothelial Injury in Sepsis
Chen, Y., Wang, J., Zhang, L., Zhu, J., Zeng, Y., & Huang, J. (2021) · Journal of Immunology Research · doi:10.1155/2021/6695679 · Cited by 15
“The mice were randomized and injected intraperitoneally with vehicle as the control or 3mg/kg (low-dose group) or 6mg/kg (high-dose group) LPS daily for two consecutive days (n = 12 per group) to induce sepsis [10, 11].”
MethodDaniels, R. C., Jun, H., Tiba, M. H., McCracken, B. M., Herrera-Fierro, P., Collinson, M. M., & Ward, K. R. (2017) · Shock · doi:10.1097/shk.0000000000000933 · Cited by 15
“Although there is much debate regarding antioxidant therapies in critical illness, there have been multiple studies demonstrating the potential benefits of these therapies, including the use of ascorbic acid to attenuate the development of organ injury (30, 31) and to reduce the proinflammatory and procoagulant states…”
Current Controversies in Sepsis Management
Moss, S. R., & Prescott, H. C. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1696981 · Cited by 15
High-Dose Intravenous Ascorbic Acid: Ready for Prime Time in Traumatic Brain Injury?
Leichtle, S. W., Sarma, A. K., Strein, M., Yajnik, V., Rivet, D. J., Sima, A. P., & Brophy, G. M. (2019) · Neurocritical Care · doi:10.1007/s12028-019-00829-x · Cited by 19
Evidence-Based Perioperative Nutrition Recommendations: Optimizing Results and Minimizing Risks
Knackstedt, R. W., Oliver, J. D., & Gatherwright, J. R. (2020) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000007004 · Cited by 15
Labbani‐Motlagh, Z., Amini, S., Aliannejad, R., Sadeghı, A., Shafiee, G., Heshmat, R., Jafary, M., Talaschian, M., Akhtari, M., Jamshidi, A., et al. (2022) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_30_22 · Cited by 17
“found that high-dose intravenous Vitamin C (HDIVC) reduces acute lung injury in animal models of acute respiratory distress syndrome (ARDS).[12,13] Furthermore, in one study on patients in the early stages of sepsis, Sequential Organ Failure Assessment (SOFA) score, C-reactive protein (CRP), and thrombomodulin levels…”
BackgroundLin, J., Li, H., Wen, Y. L., & Zhang, M. (2018) · Open Journal of Internal Medicine · doi:10.4236/ojim.2018.82015 · Cited by 15
“For example, injection of ascorbate or dehydroabietic acid (DHAA, the oxidized state of vitamin C, 200 mg/kg) increases the survival in mice that occurred with septic shock by exposure to lipopolysaccharide (LPS) [26].”
BackgroundUpdates in Sepsis Resuscitation
Ellender, T. J., & Benzoni, N. S. (2020) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2020.06.006 · Cited by 14
Effect of vitamin C in critically ill patients with sepsis and septic shock: A meta-analysis
Feng, F., Yang, H., Yang, W., Li, M., Chang, X., & Chen, Y. (2021) · Science Progress · doi:10.1177/0036850421998175 · Cited by 15
Yao, R.-Q., Zhu, Y., Yu, Y. S., Li, Z., Wang, L., Zheng, L., Li, J., Huang, H., Wu, G., Zhu, F., et al. (2021) · Burns & Trauma · doi:10.1093/burnst/tkab040 · Cited by 15
Metadata
- Authors
- Fisher, B. J., Seropian, I. M., Kraskauskas, D., Thakkar, J. N., Voelkel, N. F., Fowler, A. A., & Natarajan, R.
- Affiliations
- Virginia Commonwealth University (US)
- Venue
- Critical Care Medicine
- Published
- 2011-06
- Volume
- 39
- Issue
- 6
- Pages
- 1454-1460
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2049662677
- Semantic Scholar
- 1f52e6c58de575dfb35a1e6237c09ee37f453e6e
- Cited by
- 178
- References
- 43
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 6 · 2023: 13 · 2022: 16 · 2021: 40 · 2020: 30 · 2019: 15 · 2018: 10 · 2017: 10 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 5 · 2012: 2
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- vitamin C, dehydroascorbic acid, acute lung injury, sepsis, lipopolysaccharide, endotoxemia, NF-κB activation, coagulation, neutrophil sequestration, chemokine expression, lung barrier function, survival
- MeSH terms
- Animals, Antioxidants, Ascorbic Acid, Disease Models, Animal, Escherichia coli, Lipopolysaccharides, Male, Mice, Inbred C57BL, Sepsis, Mice, Acute Lung Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.